It also addresses multiple Alzheimer’s disease mechanisms, reducing β-amyloid aggregation, inhibiting tau hyperphosphorylation, and alleviating oxidative stress, neuroinflammation, and apoptosis (Liang and Wang, 2022). The gene discussed is MAPT; the disease is Alzheimer disease.